Vascular safety of erenumab for migraine prevention

OBJECTIVE: To examine the cardiovascular, cerebrovascular, and peripheral vascular safety of erenumab across migraine prevention studies. METHODS: Vascular adverse events (AEs) and blood pressure data were integrated across 4 double-blind, placebo-controlled studies of erenumab and their open-label...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurology
Autori principali: Kudrow, David, Pascual, Julio, Winner, Paul K., Dodick, David W., Tepper, Stewart J., Reuter, Uwe, Hong, Frank, Klatt, Jan, Zhang, Feng, Cheng, Sunfa, Picard, Hernan, Eisele, Osa, Wang, Julie, Latham, Jonathan N., Mikol, Daniel D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080286/
https://ncbi.nlm.nih.gov/pubmed/31852816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008743
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi